Transmural Biotech

Transmural Biotech is a medical technology company based in Barcelona, founded in 2009. The company specializes in developing clinical solutions that utilize advanced image analysis and artificial intelligence (AI) to enhance personalized and non-invasive healthcare. Originating as a spin-off from a clinical hospital, Transmural Biotech launched its first product, quantusFLM, which improves the speed and reliability of diagnoses from ultrasound scans. The company offers three main diagnostic products: quantusSKIN for dermatology, quantusGL for ophthalmology, and quantusFLM for maternal-fetal medicine. These products analyze subtle changes in medical images to detect tissue alterations linked to specific diseases, providing healthcare professionals with valuable diagnostic insights. Transmural Biotech is also involved in research projects focused on breast cancer, osteoporosis, and diabetic retinopathy, demonstrating its commitment to expanding its diagnostic capabilities. The company aims to improve disease diagnosis and monitoring through its innovative AI-driven solutions, ultimately enhancing patient outcomes and reducing healthcare costs.

• Employees8
• Founded2009